Home/Filings/4/0001641172-25-025446
4//SEC Filing

Leftwich Scott 4

Accession 0001641172-25-025446

CIK 0001855485other

Filed

Aug 24, 8:00 PM ET

Accepted

Aug 25, 8:47 PM ET

Size

9.2 KB

Accession

0001641172-25-025446

Insider Transaction Report

Form 4
Period: 2025-08-21
Transactions
  • Purchase

    Common Stock

    2025-08-21$2.00/sh+125,000$250,000130,650 total
  • Purchase

    Warrant (right to buy)

    2025-08-21+125,000125,000 total
    Exercise: $2.00From: 2025-08-21Exp: 2030-08-21Common stock (125,000 underlying)
Holdings
  • Common Stock

    (indirect: By LLC)
    14,672
  • Common Stock

    (indirect: By LLC)
    1,309
Footnotes (3)
  • [F1]The common stock and warrants were acquired by the reporting person in a public offering conducted by the Issuer that was closed on August 21, 2025.
  • [F2]Each common share was purchased with an accompanying warrant for a purchase price of $2.00 per share and accompanying warrant.
  • [F3]The reporting person is the managing member of SECBL, LLC and WEBCL, LLC, as such the reporting person may be deemed to have beneficial ownership of the common stock held by SECBL, LLC and WEBCL, LLC.

Documents

1 file

Issuer

Calidi Biotherapeutics, Inc.

CIK 0001855485

Entity typeother

Related Parties

1
  • filerCIK 0001991668

Filing Metadata

Form type
4
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 8:47 PM ET
Size
9.2 KB